ADMA Biologics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by ADMA Biologics, Inc. on July 16, 2013. The report pertains to corporate governance events regarding the scheduling of the company's 2013 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to Item 8.01 (Other Events) and contains no financial data.
Material Changes
There are no material financial changes reported in this filing. The sole material event is the announcement of the Annual Meeting dates.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document strictly announces the meeting logistics.
Key Facts for Investors
- Annual Meeting Date: August 8, 2013.
- Record Date: June 27, 2013 (shareholders of record on this date are eligible to vote).
- Signatory: Adam S. Grossman, President and Chief Executive Officer.
- Financial Data: None included in this specific filing.